Kidney function and sudden cardiac death in the community: the Atherosclerosis Risk in Communities (ARIC) Study
Open accessAbstract
Background Individuals with chronic kidney disease, particularly those requiring dialysis, are at high risk of sudden cardiac death (SCD). However, comprehensive data for the full spectrum of kidney function and SCD risk in the community are sparse. Furthermore, newly developed equations for estimated glomerular filtration rate (eGFR) and novel filtration markers might add further insight to the role of kidney function in SCD.Methods We investigated the associations of baseline eGFRs using serum creatinine, cystatin C, or both (eGFRcr, eGFRcys, and eGFRcr-cys); cystatin C itself; and β2-microglobulin (B2M) with SCD (205 cases through 2001) among 13,070 black and white ARIC participants at baseline during 1990-1992 using Cox regression models accounting for potential confounders.Results Low eGFR was independently associated with SCD risk: for example, hazard ratio for eGFR <45 versus ≥90mL/(min 1.73m(2)) was 3.71 (95% CI 1.74-7.90) with eGFRcr, 5.40 (2.97-9.83) with eGFRcr-cys, and 5.24 (3.01-9.11) with eGFRcys. When eGFRcr and eGFRcys were included together in a single model, the association was only significant for eGFRcys. When three eGFRs, cystatin C, and B2M were divided into quartiles, B2M demonstrated the strongest association with SCD (hazard ratio for fourth quartile vs first quartile 3.48 (2.03-5.96) vs ≤2.7 for the other kidney markers).Conclusions Kidney function was independently and robustly associated with SCD in the community, particularly when cystatin C or B2M was used. These results suggest the potential value of kidney function as a risk factor for SCD and the advantage of novel filtration markers over eGFRcr in this context.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Accelerated vascular media calcification with increased vascular stiffness is a feature of chronic kidney disease and is attributed to disordered calcium-phosphate metabolism, referred to as CKD-mineral bone disorder.
“Accelerated vascular media calcification with increased vascular stiffness is also a feature of CKD and attributed to disordered calcium-phosphate metabolism, referred to as CKD-mineral bone disorder (CKD-MBD). 690,691”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [690]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 44 · Cited by 38
- Authors
- Suzuki, T., Agarwal, S. K., Deo, R., Sotoodehnia, N., Grams, M. E., Selvin, E., Calkins, H., Rosamond, W., Tomaselli, G., Coresh, J., & Matsushita, K.
- Affiliations
- University of Mississippi Medical Center (US)
- Johns Hopkins University (US)
- University of Pennsylvania (US)
- University of Washington (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Matsushita, Kunihiro
- ORCID
- Venue
- American Heart Journal
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 180
- Pages
- 46-53
- ISSN
- 0002-8703 (ISSN-L)
- PMC
- PMC5074685
- OpenAlex
- W2471951432
- Cited by
- 38
- References
- 44
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 1 · 2012: 1
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK106414, R01DK089174)
- Kyowa Hakko Kirin
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HHSN268201100005C)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Keywords
- sudden cardiac death, renal function, estimated glomerular filtration rate, cystatin C, beta2-microglobulin, serum creatinine, chronic kidney disease, cardiovascular risk factors, Atherosclerosis Risk in Communities Study
- MeSH terms
- Creatinine, Female, Glomerular Filtration Rate, Humans, Kidney, Kidney Function Tests, Male, Middle Aged, Risk Factors, Biomarkers, Proportional Hazards Models, Death, Sudden, Cardiac, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review